Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

Grade Last Price % Change Price Change
grade C 3.79 0.80% 0.03
CPRX closed up 0.8 percent on Friday, May 17, 2019, on 71 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Up
See historical CPRX trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.80%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.80%
Calm After Storm Range Contraction 0.80%

Older signals for CPRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Health Pharmaceutical Pharmaceutical Industry California Medication Disorders Virotherapy Health Sciences Epilepsy Pharmaceutical Sciences Biomarin Pharmaceutical Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Novato Tourette Syndrome Treatment Of Epilepsy
Is CPRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.16
52 Week Low 1.85
Average Volume 3,204,578
200-Day Moving Average 3.2947
50-Day Moving Average 4.5994
20-Day Moving Average 4.632
10-Day Moving Average 3.582
Average True Range 0.5029
ADX 40.08
+DI 24.165
-DI 31.1347
Chandelier Exit (Long, 3 ATRs ) 4.6513
Chandelier Exit (Short, 3 ATRs ) 3.7387
Upper Bollinger Band 7.1248
Lower Bollinger Band 2.1392
Percent B (%b) 0.33
BandWidth 107.633851
MACD Line -0.4335
MACD Signal Line -0.2785
MACD Histogram -0.1551
Fundamentals Value
Market Cap 320.45 Million
Num Shares 84.6 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -18.95
Price-to-Sales 0.00
Price-to-Book 6.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.06
Resistance 3 (R3) 4.05 3.95 4.02
Resistance 2 (R2) 3.95 3.88 3.96 4.00
Resistance 1 (R1) 3.87 3.84 3.91 3.88 3.98
Pivot Point 3.77 3.77 3.79 3.78 3.77
Support 1 (S1) 3.69 3.70 3.73 3.70 3.60
Support 2 (S2) 3.59 3.66 3.60 3.58
Support 3 (S3) 3.51 3.59 3.57
Support 4 (S4) 3.52